RESOURCES - VUGENE

Lipid Profiling of Parkinson’s Disease Brain Highlights Disruption in Lysophosphatidylcholines and Triacylglycerol Metabolism

Today, VUGENE highlights a new study investigating the lipidomic landscape of Parkinson’s disease, revealing significant disruptions in brain lipid metabolism and uncovering potential biomarkers for early detection and therapeutic monitoring. ...

Metabolomics | For studies using targeted and untargeted metabolite mass spectrometry

How VUGENE Is Turning Massive Life Science Datasets into Biological Insights

Wading Through Vast Metabolomics Data? AI Could Help You Find Your Footing

BIO 2026: Beyond the DNA Blueprint

Choosing Your Omics

The Molecular Architecture of Severe Pediatric Traumatic Brain Injury: A Multi-Omic Longitudinal Study

VUGENE – New Approaches For “Getting Data to Confess”

Lipid Profiling of Parkinson’s Disease Brain Highlights Disruption in Lysophosphatidylcholines and Triacylglycerol Metabolism

Metabolomics